// App-Quantinova.ai

10112 : Duration of anticoagulant therapy and VTE recurrence in patients with cancer.

Researchers

Presenter

  • Alok A. Khorana

Principal Investigators

  • Keith McCrae

  • Dejan Milentijevic

  • Daniel Yannicelli

  • Jonathan Fortier

  • Winnie W. Nelson

  • Francois Laliberte

  • Concetta Crivera

  • Patrick Lefebvre

  • Jeff Schein

Medical Centers

  • Cleveland Clinic, Cleveland, OH

  • Janssen Scientific Affairs, LLC, Raritan, NJ

  • Janssen Pharmaceuticals, Raritan, NJ

  • Groupe d'analyse, Ltee, Montreal, QC, Canada

Locations

  • United States

  • Canada

Companies

  • JB Medical Ltd.

  • Janssen Global Servi

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Solid malignancies

Biomarkers

  • N/A

Drug/Treatment

  • rivaroxaban

  • Warfarin

  • Heparin

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final

Copyright © 2026. QuantiNova All rights reserved